chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd 2 doses of Engerix-B & 3 days following dose 2, pt exp burning @ the site of inject & a vesicle formed that was extremely tender, even to shirt sleeve;
The day he received his vaccine on 02/05/2022, he had more than normal bowel movements. He kept going to the bathroom more than normal, but I didn't think anything of it. On 02/06/2022, he was acting out of his norm. He had a high fever 103 degree fever, so I gave him Tylenol; he had had extreme diarrhea and loose bowel. He had no appetite and was extremely fatigued and dehydrated. Around 8pm, he had a slight appetite so I fed him something small. His fever broke early Monday morning around 1am at night on 02/07/2022. He still felt fatigue, was somewhat constipated, and was crying heavy tears that his chest was hurting and was pointing above his heart. So I took him to the doctor at Physicians; the doctor ordered an EKG and chest x-ray, and the pediatrician didn't see anything abnormal in the charts.
8/25-8/27 Pins & needles tingling that started in fingers & toes & progressed up all extremities and then started on the nose & cheeks. Extreme muscle fatigue in legs with some loss of strength & shaking with exertion head felt extremely heavy and neck was tierd just holding it up.  On 27th, was immediately sent to ER to be evaluated for Gillian-barre during visit all blood work came back normal, negative stroke assessment, but was noted to have loss of "sharp" sensation when poked with a needle I could not feel it, tremor in hands & muscle weakness during my neurological exam. Was sent home to monitor my symptoms & told by the ER doctor it just seemed to be an adverse reaction to the
This spontaneous report as received from a certified medical assistant to an 16 year old patient of an unknown gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. Approximately in 2015 (reported as 27-AUG-2015 to 03-SEP-2015) the patient was vaccinated with improperly stored dose of GARDASIL lot # K010215 with expiration date 05-MAY-2017 or lot # K011562 with expiration date 08-APR-2017; dose and route of administration were not reported. No adverse experiences were reported. This is one of the several reports received from same reporter. Additional information has been requested.
Headache, body aches, chills, fatigue, fever, pain at injection site,  muscle pain
Arm swollen, red, patient cold all night couldn't sleep, felt terrible. Patient went to work next day for a brief time, back home slept all day, chilled, decreased appetite. Somewhat better 2 days later but not 100%.
Pt recv vax on 4/28/99; on 4/29/99 pt exp febrile seizure w/ fever (41.4C)
Pt's rt upper arm was swollen & red w/ the inner portion also appearing red & swollen or itchy in appearance.Small blisters to center of arm region.
Caller had the first dose of the Pfizer vaccine today, July 28 2021 and has sinus ear infection; This is a spontaneous report from a Pfizer- sponsored program. A contactable male consumer reported for himself. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0164), via an unspecified route of administration on 28Jul2021 as single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included amoxicillin and Antibiotics (unspecified) taken for an unspecified indication, start and stop date were not reported. It was reported that, caller had the first dose of the Pfizer vaccine today, 28Jul2021 and has sinus ear infection, patient was on antibiotics for a while. Patient got a steroid shot 2-3 weeks ago (further clarification unknown). Later Transferring agent stated Caller had the first dose of the Pfizer vaccine today (28Jul2021), 28Jul2021 and has sinus ear infection and he wanted to know if he can get Amoxicillin or Steroids in between the doses because his second dose will be on 18Aug2021. It was reported that When paraphrased, consumer stated, it was not from the shot. Patient had this before patient got the shot. (Further clarification unknown). When probed since when consumer had the sinus ear infection, consumer stated, patient have been having sinus problem for a while. So, patient was on antibiotics for a while. Patient got a steroid shot 2-3 weeks ago (Further clarification unknown). Consumer stated, question was patient need to get more antibiotics for the ear infection, but the question was because patient have to take the second shot can patient take the antibiotics between the first dosage and second dosage, does it have to be out of his system like week before the shot How does it work. Therapeutic measures were taken as a result of event. The outcome of event was unknown.
Erythemia Multiform & UrticariaPruritus Adverse Event Description 12/30 soreness, swelling and tenderness to injection site. 12/31 light-head until 1/7. 1/6 redness, sore, itchiness, hard lump at injection site and 1 in. below injection, took loratadine at bedtime. 1/8  redness spreading but lump is not as hard
Patient complaining of pain in the muscle that radiated down her arm and is still complaining that the pain has not subsided completely as of 10/25/2016.  She thinks a nerve was hit by the needle high on her arm.
loud tinnitus; vertigo; An increase in frequency of and intensity of migraines; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 56-year-old female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EN6204) via an unspecified route of administration in right arm on 19Mar2021 13:00 as dose 1, single (at the age of 56-years-old) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient medical history included migraines, seizure disorder, three years of out breast cancer, high blood pressure. Patient known allergies included allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced very loud tinnitus in right ear, self spinning vertigo and an increase in frequency of and intensity of migraines on 23Mar2021. The adverse events resulted in a visit to Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of loud tinnitus, vertigo, migraines. The outcome of the event was not recovered.  No Follow-up attempts are possible. Information about lot/batch number cannot be obtained.  Follow-up attempts have been completed and No further information is expected.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On 03-FEB-2014, the patient was vaccinated with a dose of improperly stored PEDVAXHIB lot # reported as J005672, expiration date reported as 05-DEC-2015 (dose and route were not reported). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Fever up to 101.5, varies to 99.4. Body aches. Cough. Chills.
Light headache; Flushed cheeks; Tenderness near my heart; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional. A 31-year-old female patient received bnt162b2 (Pfizer/BioNTech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EW0171) intramuscularly, administered in right arm on 29Apr2021 12:50 (at the age of 31-year-old) as dose 1, single for covid-19 immunization. Medical history reported as none and family history included Diabetes, High blood pressure, cancer (reported as Diabetes, high blood pressure, cancer run in her family) from an unknown date and unknown if ongoing. Concomitant medications reported as none. Prior vaccination reported as none. On an unspecified date in 2021 the patient experienced light headache, flushed cheeks, tenderness near her heart. Outcome of the events were unknown.  Follow-up attempts are completed. No further information is expected.
Back of patient's arm is red and hot to the touch and swollen. There is a large red area that is 10 inches long by 6 inches wide with a smaller dark red circle in the middle that is 4 inches long and 3 inches wide.
Pt has rash in patches on various parts of body - pt is taking BENADRYL.
Blister or pimple on skin all over the body; He is up all night; Boil; It is getting worse and worse/suffered terribly; chills; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister or pimple on skin all over the body), INSOMNIA (He is up all night), FURUNCLE (Boil), FEELING ABNORMAL (It is getting worse and worse/suffered terribly) and CHILLS (chills) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Chronic obstructive pulmonary disease.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (Blister or pimple on skin all over the body), INSOMNIA (He is up all night), FURUNCLE (Boil), FEELING ABNORMAL (It is getting worse and worse/suffered terribly) and CHILLS (chills). The patient was treated with CALAMINE for Blister, at an unspecified dose and frequency and MAGNESIUM SULFATE (EPSON) for Blister, at a dose of UNK dosage form. At the time of the report, BLISTER (Blister or pimple on skin all over the body), INSOMNIA (He is up all night), FURUNCLE (Boil), FEELING ABNORMAL (It is getting worse and worse/suffered terribly) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported.   This case was linked to MOD-2021-073261 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Added the event (Chills), Second dose of the vaccine. Denied follow up; Sender's Comments: Very limited information regarding these events have been provided at this time. No further information is expected at this time.
Pt states that following am, noticed arm was red, hot and swollen. Showed his mother around 930 pm that night. MOC called clinic around 440ish on 10/4/12 and info clinic of reaction. Had pt RTC. Redness has gone down and swelling is gone. Pt adv to use ice compress.
Vaccine administered after 3 days after the time from first puncture the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days after the time from first puncture the vial) in a 92-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days after the time from first puncture the vial). On 05-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days after the time from first puncture the vial) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant were reported. No treatment were reported.   This case was linked to MOD-2021-333546 (Patient Link).
Fever at 103.1; Chills; Body aches; Fatigue; Headache; First dose administered on 19Dec2020; second dose administered on 07Jan2021; This is a spontaneous report from a non-contactable nurse (patient). A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (12:00) (Lot number: EL0140; Expiration date was not reported), and then the second dose on 07Jan2021 (06:00) (Lot number: EK9231; Expiration date was not reported), both intramuscularly on the left arm at a single dose for COVID-19 immunization at the hospital. The patient's medical history and concomitant medications were not reported. The patient's first vaccine dose was received on 19Dec2020, and the second dose was received on 07Jan2021 (06:00). On 07Jan2021 (23:00), the patient had fever at 103.1 (unit was not reported); chills; body aches; fatigue; and headache. The patient did not receive any treatment for the reported adverse events. The outcome of the events was recovering for 'fever at 103.1 (unit was not reported)', 'chills', 'body aches', 'fatigue' and 'headache'; and was unknown for 'first vaccine dose was received on 19Dec2020, and the second dose was received on 07Jan2021'. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested since the vaccination.  No follow-up attempts are possible. No further information is expected.
Headache & Myalgia Narrative: Seen by Provider. Claritin & Tylenol declined by employee.
My cycle started unexpectedly 2 weeks early.  My cycle is predictably 28 days like clock work and it started on day 17 vs 28.
Injection arm swelling, myalgia, erythema/redness radiating down entire arm. Sweats and chills without identified fever.
This spontaneous report as received from a physician refers to a unspecified number of patients of unknown age. The unspecified patients medical history was not reported. On an unspecified dates since 05-MAY-2014, an unspecified number of patients received PROQUAD (Merck) (lot # K007799 and expiry date: 29-NOV-2015) which was improperly exposed to 22F for 1920 hours. No known adverse effects. No product complaint was reported for PROQUAD (Merck). This case is linked to 1411USA001655, 1411USA004432, 1411USA004433, 1411USA004434, 1411USA004435, 1411USA004436, 1411USA004437, 1411USA004439, 1411USA004440, 1411USA004441 and 1411USA004442 (same reporter link). Additional information has been requested.
clusters of bumps at the base of her back, both shoulders, one on the left hip, and under the right breast and the front left side of her neck; Blisters; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   In September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced itchy rash and blister. On an unknown date, the outcome of the itchy rash and blister were recovering/resolving.   It was unknown if the reporter considered the itchy rash and blister to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient after getting the Shingrix vaccine, she broke out in, she got more break outs in her vaginal area, on the right thigh, right base of the head, and the front left side of her neck. The patient described that the rash was itchy and they were blisters. This case has been linked to US2019222795, reported by the same reporter.
poss sz parents described pt as unresponsive, eyes rolled back in head; no shaking lasting 5 mins; pt brought back to clinic & had nl PE;
Developed fever, neck stiffness, myalgias and tics (head movements) within 24 hours of receiving vaccine. Tics and neck stiffness have persisted as of visit today 9/15/11 though slightly improving.
Received Moderna vaccines on 1/30/21, 3/5/21 COVID-19 positive by PCR on  1/14/22 hospital admission 1/14/22 d/t COVID pneumonia underlying HTN, DM2,  chronic hypoxic and hypercapnic respiratory failure (on continuous 3 LPM oxygen supplementation with AVAPS overnight),
Pt devel a rash 2 to 3 wks p/receiving Engerix-B tx DPH; reporter indicates questionable attribution to Engerix-B since rash onset was 2 to 3 wks post vax; undecided as to continuing w/vax series;  also devel hives;
pt recvd vax & exp burning @ inject site during vax w/Hep B;
received shingrix /was under 50 years /was not /immunocompromised; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 47-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th November 2019, the patient received the 1st dose of Shingrix. On 10th November 2019, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.  Additional details were provided as follows: The patient received 1st dose and the patient was under 50 years of age and was not considered immunocompromised, which led to inappropriate age at vaccine administration. The patient never got the 2nd dose. The reporter consented to follow up.
I just had covid; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (I just had covid) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (I just had covid). At the time of the report, COVID-19 (I just had covid) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.  This is a spontaneous case concerning a patient of unknown age and gender with no medical history reported, who experienced the unexpected event of Covid-19. The event occurred on an unknown date, while the received second dose of mRNA  1273 vaccine was on April 2021. At the time of report outcome was still unknown. The rechallenge is not applicable since no information about the first dose was disclosed. The reporter's assessment was not provided. The benefit-risk relationship of the vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender with no medical history reported, who experienced the unexpected event of Covid-19. The event occurred on an unknown date, while the received second dose of mRNA  1273 vaccine was on April 2021. At the time of report outcome was still unknown. The rechallenge is not applicable since no information about the first dose was disclosed. The reporter's assessment was not provided. The benefit-risk relationship of the vaccine is not affected by this report.
Information has been received from a RN concerning a 49 year old obese female with dyslipidemia who on approximately 3/9/03, "a little over a month ago," was vaccinated with a dose of hep B vaccine. There was no concomitant medication. On approximately 3/14/03, in the weeks after the vaccination, the pt developed a fever, joint aches (especially in her shoulders and knees), pimples on her face, and a numb forehead. Unspecified medical attention was sought. Additional info has been requested.
Information has been received from a physician concerning a 35 month old white male pt with no pre-existing allergies or medical conditions, who on 19Nov03 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (lot 646235/0828N). Concomitant vaccine therapy administered on the same day, 19Nov03 included a first SC dose in the right arm of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 641629/0667N) and a first IM dose of influenza virus split virion 3v vaccine inactivated (Fluzone) (lot U1091AA) administered in the left arm. It was noted that the pt developed a rash and was seen in the office with a three day history of rash on his inner thigh and knee. Onset was reported as 11OCT05. The rash was reported as somewhat itchy and there was no fever. The rash was in clusters of vesicles on erythematous base and isolated to L-3 dermatome on left lower extremities. As per the pt's mother the pt had varicella vaccine with routine immunizations at 1 year of age. There was no history of wild type illness. Follow up information received on 28Oct05 contained the following adverse experience: respiratory infection illness (approx 07Oct05). Additional information has been requested. The physician also reported a case of chickenpox in the pt's unvaccinated family members (female twins) (WAES0506USA00501 and 0506USA00815).
Wrong vaccine formulation received.  Patient should have received 12+ formulation booster dose. Received Ped 6m-5y formulation half dose in error.
a number of minutes after receiving the vaccine, patient fainted while seated, fell backwards in his chair, and hit his head on the floor.  as a result of the fall, the back of his head was cut.  he remained on the floor and gauze was held against the cut to slow/stop the bleeding until the ambulance service arrived.  Patient was taken to the hospital for treatment of the cut.  Patient is currently in good health.
I was exposed to COVID-19 from my husband who is a mail man. He tested positive on 07/21/2022. He began to isolate on a different level of the home after testing positive. However, on 07/23/2022 I had to take a pretty long nap and may have had a bit of a cough. Sunday morning, I woke up with a cough and a serious sore throat, so I decided to take and at home COVID-19 test and it was positive. As that day progressed, I started developing a headache. I called my doctor's office the next day and left a message to see if I qualified for antiviral medication. I picked up the PAXLOVID prescription that after noon 07/25/22 and began taking it that evening at around 5:30. That Tuesday, I had lost my sense of taste, had a major headache, fatigue, and was coughing a lot. I'm approaching the 10-day mark and I am still very tired and coughing a lot. I took an at home test this morning 08/02/2022 and it was negative, but I am still suffering from some of the symptoms just not as severely.
Had Shot on 3-5-2021 Arm started itching on 3-6-2021 and have a rash from shoulder to elbow on 3-7-2021 Still have the rash called the doctor he said to put Ice on it and to take Benadryl
6 mo vaccine given at noon on 1/9/2012 baby was more "sleepy" per mom that evening woke at 0130/mom took temp which was 104.5 degrees F axillary gave TYLENOL had "tremors" every 20 min until 0500. More "sleepy" today than usual.
Genital Herpes Flare; This case was reported by a other health professional via call center representative and described the occurrence of genital herpes in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, several hours after receiving Shingrix, the patient experienced genital herpes. On an unknown date, the outcome of the genital herpes was unknown.   It was unknown if the reporter considered the genital herpes to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported a worsening of her Herpes flare symptoms a few months after receiving the 1st dose of Shingrix. The therapist stated she did not reside in the US and declined to provide any data.